These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 17372630)

  • 21. Therapeutic management of chronic neuropathic pain: an examination of pharmacologic treatment.
    Vadalouca A; Siafaka I; Argyra E; Vrachnou E; Moka E
    Ann N Y Acad Sci; 2006 Nov; 1088():164-86. PubMed ID: 17192564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analgesic therapy in postherpetic neuralgia: a quantitative systematic review.
    Hempenstall K; Nurmikko TJ; Johnson RW; A'Hern RP; Rice AS
    PLoS Med; 2005 Jul; 2(7):e164. PubMed ID: 16013891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EFNS guidelines on pharmacological treatment of neuropathic pain.
    Attal N; Cruccu G; Haanpää M; Hansson P; Jensen TS; Nurmikko T; Sampaio C; Sindrup S; Wiffen P;
    Eur J Neurol; 2006 Nov; 13(11):1153-69. PubMed ID: 17038030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interventions for Neuropathic Pain: An Overview of Systematic Reviews.
    Dosenovic S; Jelicic Kadic A; Miljanovic M; Biocic M; Boric K; Cavar M; Markovina N; Vucic K; Puljak L
    Anesth Analg; 2017 Aug; 125(2):643-652. PubMed ID: 28731977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Review of current guidelines on the care of postherpetic neuralgia.
    Argoff CE
    Postgrad Med; 2011 Sep; 123(5):134-42. PubMed ID: 21904096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia: a Canadian perspective.
    Tarride JE; Gordon A; Vera-Llonch M; Dukes E; Rousseau C
    Clin Ther; 2006 Nov; 28(11):1922-34. PubMed ID: 17213013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Update in the pharmacological treatment of neuropathic pain].
    Alcántara Montero A; Ibor Vidal PJ; Alonso Verdugo A; Trillo Calvo E
    Semergen; 2019; 45(8):535-545. PubMed ID: 31337589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of Pregabalin in Patients with Neuropathic Pain Previously Treated with Gabapentin: A Pooled Analysis of Parallel-Group, Randomized, Placebo-controlled Clinical Trials.
    Markman JD; Jensen TS; Semel D; Li C; Parsons B; Behar R; Sadosky AB
    Pain Pract; 2017 Jul; 17(6):718-728. PubMed ID: 27611736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An investigation of factors contributing to higher levels of placebo response in clinical trials in neuropathic pain: a systematic review and meta-analysis.
    Arakawa A; Kaneko M; Narukawa M
    Clin Drug Investig; 2015 Feb; 35(2):67-81. PubMed ID: 25559268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New developments in the treatment algorithm for peripheral neuropathic pain.
    de Leon-Casasola O
    Pain Med; 2011 Jul; 12 Suppl 3():S100-8. PubMed ID: 21752181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oxycodone for neuropathic pain and fibromyalgia in adults.
    Gaskell H; Moore RA; Derry S; Stannard C
    Cochrane Database Syst Rev; 2014 Jun; (6):CD010692. PubMed ID: 24956205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical practice guidelines for management of neuropathic pain: expert panel recommendations for South Africa.
    Chetty S; Baalbergen E; Bhigjee AI; Kamerman P; Ouma J; Raath R; Raff M; Salduker S;
    S Afr Med J; 2012 Mar; 102(5):312-25. PubMed ID: 22554341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacotherapy of neuropathic pain: which drugs, which treatment algorithms?
    Attal N; Bouhassira D
    Pain; 2015 Apr; 156 Suppl 1():S104-S114. PubMed ID: 25789426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. French guidelines for neuropathic pain: An update and commentary.
    Moisset X; Bouhassira D; Attal N
    Rev Neurol (Paris); 2021 Sep; 177(7):834-837. PubMed ID: 34332778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacology and treatment of neuropathic pains.
    Jensen TS; Madsen CS; Finnerup NB
    Curr Opin Neurol; 2009 Oct; 22(5):467-74. PubMed ID: 19741531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An open-label comparison of nabilone and gabapentin as adjuvant therapy or monotherapy in the management of neuropathic pain in patients with peripheral neuropathy.
    Bestard JA; Toth CC
    Pain Pract; 2011; 11(4):353-68. PubMed ID: 21087411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosis and management of neuropathic pain: review of literature and recommendations of the Polish Association for the study of pain and the Polish Neurological Society - part one.
    Szczudlik A; Dobrogowski J; Wordliczek J; Stępień A; Krajnik M; Leppert W; Woroń J; Przeklasa-Muszyńska A; Kocot-Kępska M; Zajączkowska R; Janecki M; Adamczyk A; Malec-Milewska M
    Neurol Neurochir Pol; 2014; 48(4):262-71. PubMed ID: 25168326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Update on pharmacotherapy guidelines for the treatment of neuropathic pain.
    Dobecki DA; Schocket SM; Wallace MS
    Curr Pain Headache Rep; 2006 Jun; 10(3):185-90. PubMed ID: 18778572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacologic management part 1: better-studied neuropathic pain diseases.
    Backonja MM; Serra J
    Pain Med; 2004 Mar; 5 Suppl 1():S28-47. PubMed ID: 14996228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective Cannabinoids for Chronic Neuropathic Pain: A Systematic Review and Meta-analysis.
    Meng H; Johnston B; Englesakis M; Moulin DE; Bhatia A
    Anesth Analg; 2017 Nov; 125(5):1638-1652. PubMed ID: 28537982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.